Cargando…
Cytotoxicity screening of 23 engineered nanomaterials using a test matrix of ten cell lines and three different assays
BACKGROUND: Engineered nanomaterials display unique properties that may have impact on human health, and thus require a reliable evaluation of their potential toxicity. Here, we performed a standardized in vitro screening of 23 engineered nanomaterials. We thoroughly characterized the physicochemica...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3059267/ https://www.ncbi.nlm.nih.gov/pubmed/21345205 http://dx.doi.org/10.1186/1743-8977-8-9 |
_version_ | 1782200395617009664 |
---|---|
author | Kroll, Alexandra Dierker, Christian Rommel, Christina Hahn, Daniela Wohlleben, Wendel Schulze-Isfort, Christian Göbbert, Christian Voetz, Matthias Hardinghaus, Ferdinand Schnekenburger, Jürgen |
author_facet | Kroll, Alexandra Dierker, Christian Rommel, Christina Hahn, Daniela Wohlleben, Wendel Schulze-Isfort, Christian Göbbert, Christian Voetz, Matthias Hardinghaus, Ferdinand Schnekenburger, Jürgen |
author_sort | Kroll, Alexandra |
collection | PubMed |
description | BACKGROUND: Engineered nanomaterials display unique properties that may have impact on human health, and thus require a reliable evaluation of their potential toxicity. Here, we performed a standardized in vitro screening of 23 engineered nanomaterials. We thoroughly characterized the physicochemical properties of the nanomaterials and adapted three classical in vitro toxicity assays to eliminate nanomaterial interference. Nanomaterial toxicity was assessed in ten representative cell lines. RESULTS: Six nanomaterials induced oxidative cell stress while only a single nanomaterial reduced cellular metabolic activity and none of the particles affected cell viability. Results from heterogeneous and chemically identical particles suggested that surface chemistry, surface coating and chemical composition are likely determinants of nanomaterial toxicity. Individual cell lines differed significantly in their response, dependent on the particle type and the toxicity endpoint measured. CONCLUSION: In vitro toxicity of the analyzed engineered nanomaterials cannot be attributed to a defined physicochemical property. Therefore, the accurate identification of nanomaterial cytotoxicity requires a matrix based on a set of sensitive cell lines and in vitro assays measuring different cytotoxicity endpoints. |
format | Text |
id | pubmed-3059267 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-30592672011-03-17 Cytotoxicity screening of 23 engineered nanomaterials using a test matrix of ten cell lines and three different assays Kroll, Alexandra Dierker, Christian Rommel, Christina Hahn, Daniela Wohlleben, Wendel Schulze-Isfort, Christian Göbbert, Christian Voetz, Matthias Hardinghaus, Ferdinand Schnekenburger, Jürgen Part Fibre Toxicol Research BACKGROUND: Engineered nanomaterials display unique properties that may have impact on human health, and thus require a reliable evaluation of their potential toxicity. Here, we performed a standardized in vitro screening of 23 engineered nanomaterials. We thoroughly characterized the physicochemical properties of the nanomaterials and adapted three classical in vitro toxicity assays to eliminate nanomaterial interference. Nanomaterial toxicity was assessed in ten representative cell lines. RESULTS: Six nanomaterials induced oxidative cell stress while only a single nanomaterial reduced cellular metabolic activity and none of the particles affected cell viability. Results from heterogeneous and chemically identical particles suggested that surface chemistry, surface coating and chemical composition are likely determinants of nanomaterial toxicity. Individual cell lines differed significantly in their response, dependent on the particle type and the toxicity endpoint measured. CONCLUSION: In vitro toxicity of the analyzed engineered nanomaterials cannot be attributed to a defined physicochemical property. Therefore, the accurate identification of nanomaterial cytotoxicity requires a matrix based on a set of sensitive cell lines and in vitro assays measuring different cytotoxicity endpoints. BioMed Central 2011-02-23 /pmc/articles/PMC3059267/ /pubmed/21345205 http://dx.doi.org/10.1186/1743-8977-8-9 Text en Copyright ©2011 Kroll et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Kroll, Alexandra Dierker, Christian Rommel, Christina Hahn, Daniela Wohlleben, Wendel Schulze-Isfort, Christian Göbbert, Christian Voetz, Matthias Hardinghaus, Ferdinand Schnekenburger, Jürgen Cytotoxicity screening of 23 engineered nanomaterials using a test matrix of ten cell lines and three different assays |
title | Cytotoxicity screening of 23 engineered nanomaterials using a test matrix of ten cell lines and three different assays |
title_full | Cytotoxicity screening of 23 engineered nanomaterials using a test matrix of ten cell lines and three different assays |
title_fullStr | Cytotoxicity screening of 23 engineered nanomaterials using a test matrix of ten cell lines and three different assays |
title_full_unstemmed | Cytotoxicity screening of 23 engineered nanomaterials using a test matrix of ten cell lines and three different assays |
title_short | Cytotoxicity screening of 23 engineered nanomaterials using a test matrix of ten cell lines and three different assays |
title_sort | cytotoxicity screening of 23 engineered nanomaterials using a test matrix of ten cell lines and three different assays |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3059267/ https://www.ncbi.nlm.nih.gov/pubmed/21345205 http://dx.doi.org/10.1186/1743-8977-8-9 |
work_keys_str_mv | AT krollalexandra cytotoxicityscreeningof23engineerednanomaterialsusingatestmatrixoftencelllinesandthreedifferentassays AT dierkerchristian cytotoxicityscreeningof23engineerednanomaterialsusingatestmatrixoftencelllinesandthreedifferentassays AT rommelchristina cytotoxicityscreeningof23engineerednanomaterialsusingatestmatrixoftencelllinesandthreedifferentassays AT hahndaniela cytotoxicityscreeningof23engineerednanomaterialsusingatestmatrixoftencelllinesandthreedifferentassays AT wohllebenwendel cytotoxicityscreeningof23engineerednanomaterialsusingatestmatrixoftencelllinesandthreedifferentassays AT schulzeisfortchristian cytotoxicityscreeningof23engineerednanomaterialsusingatestmatrixoftencelllinesandthreedifferentassays AT gobbertchristian cytotoxicityscreeningof23engineerednanomaterialsusingatestmatrixoftencelllinesandthreedifferentassays AT voetzmatthias cytotoxicityscreeningof23engineerednanomaterialsusingatestmatrixoftencelllinesandthreedifferentassays AT hardinghausferdinand cytotoxicityscreeningof23engineerednanomaterialsusingatestmatrixoftencelllinesandthreedifferentassays AT schnekenburgerjurgen cytotoxicityscreeningof23engineerednanomaterialsusingatestmatrixoftencelllinesandthreedifferentassays |